Clinical effects of the CD13/CD33 ratio on the prognosis of myelodysplastic syndrome treated with azacitidine. [electronic resource]
Producer: 20210427Description: 1250-1253 p. digitalISSN:- 1029-2403
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.